Gene: CHD3
Official Full Name: chromodomain helicase DNA binding protein 3provided by HGNC
Gene Summary: This gene encodes a member of the CHD family of proteins which are characterized by the presence of chromo (chromatin organization modifier) domains and SNF2-related helicase/ATPase domains. This protein is one of the components of a histone deacetylase complex referred to as the Mi-2/NuRD complex which participates in the remodeling of chromatin by deacetylating histones. Chromatin remodeling is essential for many processes including transcription. Autoantibodies against this protein are found in a subset of patients with dermatomyositis. Three alternatively spliced transcripts encoding different isoforms have been described. [provided by RefSeq, Jul 2008]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO02900 | CHD3 Knockout cell line (HeLa) | Human | CHD3 | 1:3~1:6 | Negative | Online Inquiry |
KO02901 | CHD3 Knockout cell line (HCT 116) | Human | CHD3 | 1:2~1:4 | Negative | Online Inquiry |
KO02902 | CHD3 Knockout cell line (HEK293) | Human | CHD3 | 1:3~1:6 | Negative | Online Inquiry |
KO02903 | CHD3 Knockout cell line (A549) | Human | CHD3 | 1:3~1:4 | Negative | Online Inquiry |
CHD3 Gene Knockout Cell Lines are specifically engineered cellular models that have undergone precise genetic modification to disrupt the CHD3 gene, which plays a critical role in chromatin remodeling and gene regulation. These cell lines provide researchers with invaluable tools for investigating the functional implications of CHD3 loss on cellular processes, including cell division, differentiation, and response to various stimuli.
The primary function of the CHD3 Gene Knockout Cell Lines is to allow for detailed analyses of the biochemical pathways and physiological responses influenced by the CHD3 protein. By employing CRISPR-Cas9 technology, these cell lines exhibit a complete disruption of the CHD3 coding sequence, ensuring the absence of functional protein. This knockout enables scientists to study changes in gene expression, chromatin architecture, and downstream effects on cellular behavior in a controlled environment.
The scientific importance of CHD3 Gene Knockout Cell Lines lies in their applicability in basic research as well as translational medicine. They serve as models for understanding epigenetic regulation in various diseases such as cancer and developmental disorders. Additionally, their use can pave the way for the development of targeted therapies that modulate chromatin remodeling activities.
One key advantage of these cell lines over alternative methods, such as traditional RNA interference, is the stable and heritable knockout, which allows for reproducibility in experimental outcomes. Furthermore, the specificity of the CRISPR-Cas9 approach minimizes off-target effects, enhancing the reliability of experimental data.
For researchers and clinicians, the availability of CHD3 Gene Knockout Cell Lines is crucial for advancing studies in gene function and epigenetics. Their propensity to mimic the pathogenic mechanisms occurring in vivo makes them indispensable tools for elucidating disease mechanisms and evaluating potential therapeutic strategies.
Our company prides itself on its expertise in developing high-quality biological products, ensuring that researchers have access to cutting-edge tools that drive innovation and discovery in life sciences.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.